U.S. Smart Inhalers Market Size & Outlook, 2023-2030

The smart inhalers market in the United States is expected to reach a projected revenue of US$ 19,488.3 million by 2030. A compound annual growth rate of 17.8% is expected of the United States smart inhalers market from 2024 to 2030.
Revenue, 2023 (US$M)
$6,206.1
Forecast, 2030 (US$M)
$19,488.3
CAGR, 2024 - 2030
17.8%
Report Coverage
U.S.

U.S. smart inhalers market highlights

  • The U.S. smart inhalers market generated a revenue of USD 6,206.1 million in 2023 and is expected to reach USD 19,488.3 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 17.8% from 2024 to 2030.
  • In terms of segment, metered dose inhalers (mdis) was the largest revenue generating type in 2023.
  • Metered Dose Inhalers (MDIs) is the most lucrative type segment registering the fastest growth during the forecast period.


Smart inhalers market data book summary

Market revenue in 2023USD 6,206.1 million
Market revenue in 2030USD 19,488.3 million
Growth rate17.8% (CAGR from 2023 to 2030)
Largest segmentMetered dose inhalers (mdis)
Fastest growing segmentMetered Dose Inhalers (MDIs)
Historical data2017 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDry Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs)
Key market players worldwideAptarGroup Inc, Adherium Ltd, Teva Pharmaceutical Industries Ltd, Propeller Health, Novartis AG ADR, 3M Co, H&T Presspart Manufacturing, Cohero Health, Cognita Labs, Amiko, Pneuma Respiratory, AireHealth, FindAir


Other key industry trends

  • In terms of revenue, U.S. accounted for 40.2% of the global smart inhalers market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. smart inhalers market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 2,702.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Smart Inhalers Market Companies

Name Profile # Employees HQ Website

U.S. smart inhalers market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to smart inhalers market will help companies and investors design strategic landscapes.


Metered dose inhalers (mdis) was the largest segment with a revenue share of 63.68% in 2023. Horizon Databook has segmented the U.S. smart inhalers market based on dry powdered inhalers (dpis), metered dose inhalers (mdis) covering the revenue growth of each sub-segment from 2017 to 2030.


Reasons to subscribe to U.S. smart inhalers market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. smart inhalers market databook

  • Our clientele includes a mix of smart inhalers market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. smart inhalers market, including forecasts for subscribers. This country databook contains high-level insights into U.S. smart inhalers market from 2017 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. smart inhalers market report size, by type, 2017-2030 (US$M)

U.S. Smart Inhalers Market Share, 2023 & 2030 (US$M)

U.S. smart inhalers market report size, by type, 2017-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more